1564804800 AngelCentral Deep Dive Series: Understanding and Investing in B2B SaaS startups | SGInnovate
×
 
 Back to all events

AngelCentral Deep Dive Series: Understanding and Investing in B2B SaaS startups

 

Aug 03 2019, Saturday09:00 AM - 12:00 PM Singapore

 

32 Carpenter Street

, Singapore

, 139955
0%

Overview

Are you keen to understand and find out how to invest in startups in the B2B SaaS space?

Hear from Mr Leong Chee Tung, CEO of EngageRocket, a HR tech startup that helps to automate employee experience insights across the lifecycle of each employee. Over his years of experience in running EngageRocket, Chee Tung has developed a detailed understanding of how best to invest in B2B SaaS startups, key metrics to look out for, etc.

The workshop will provide angels with the framework and evaluation methodology to understand, evaluate and invest in early-stage e-B2B SaaS startups.

Date: 3 August 2019, Saturday
Time:9:00am 12:00pm
Venue:Perl & Java @ BASH, Level 3, 79 Ayer Rajah Crescent, Singapore 139955

About AngelCentral:
AngelCentral is a community of 500 (and counting!) angels who are passionate and interested in helping fund startups in Southeast Asia. They organise regular curated pitch sessions, angel education workshops and provide syndication services. As of July 2018, AngelCentral has trained more than 200 angels, featured more than 40 startups, and raised over S$5.8m worth of funding interest in total. The community is led by the former co-founders of JobsCentral, Der Shing and Shao-Ning, as well as former Corporate Vice President of Motorola, Teck Moh. Together, they have more than 40 years of experience in building, mentoring and investing in startups.

Some examples of startups that have pitched with AngelCentral include EngageRocket, an employee engagement HR startup which raised S$450k in 2017; Affable, an Entrepreneur First startup which raised S$1m in a seed funding round led by Decacorn Capital (which SGInnovate also participated); and caregiving services startup Homage, which recently raised US$4.15m in a Series A funding, led by Golden Gate Ventures and HealthXCapital.

Technology: